Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Cancer. 2011 May 16;118(2):326–332. doi: 10.1002/cncr.26144

Table 2.

Multivariable logistic regression model for pCR

Odds Ratio 95% CI P

Bisphosphonates use: yes v. no 2.18 0.90 to 5.24 0.08
Age: ≥ 50 versus < 50 0.66 0.48 to 0.92 0.015
Stage: III vs I/II 0.69 0.5 to 0.96 0.026
Grade: III vs I/II 3.80 2.37 to 6.07 <.001
Subtype: HER2 positive vs Hormone positive 3.02 1.97 to 4.64 <.001
Subtype: Triple negative vs Hormone positive 2.66 1.8 to 3.93 0.011
LVI: positive vs negative 0.38 0.26 to 0.57 <.001
BMI: overweight vs normal 0.69 0.46 to 1.04 0.022
BMI: obese vs normal 1.09 0.75 to 1.59 0.10

pCR = pathologic complete response; HER2 = human epidermal growth factor receptor 2; LVI = lymphovascular invasion; BMI = body mass index; CI = confidence interval.